Home   ->   about us   ->   Our History

Our History

2000 Founded
2001—2002 Established discovery chemistry services
2003 Established process development services
2004 Established manufacturing services
2005 Established bioanalytical operation
2006 Established service biology operation
Opened Tianjin campus
2007 Established toxicology & formulation services
Listed on NYSE
2008 Acquired AppTec
Established integrated service
2009 Opened Suzhou toxicology facility
2010 Opened STA large-scale manufacturing facility
2011 Established WuXi Genome Center
Established biologics services
Acquired Abgent
Established antibody and biological research reagent manufacturing and sales services
Established clinical and regulatory services
Acquired MedKey
2012 Opened Wuhan site
Opened Wuxi cGMP biologics manufacturing facility
2013 WuXiPRA began operation
STA Passed US FDA Inspection
Genomics Clinical Laboratory Received CLIA Certification
2014 Acquired XBL
Expanded materials characterization testing facility in St. Paul
Built new cell therapy manufacturing facility in Philadelphia
Built Changzhou cGMP manufacturing campus
Began operation of HPAPI lab
2015 Acquired NextCODE
STA listed on New Third Board in China
Built mammalian cell culture manufacturing facility in Wuxi
Launched LabNetwork
Launched OncoWuXi
Launched preclinical medical device testing services in China
Completed private transaction